TP53 and acute myeloid leukemia: In addition, HDAC8 was upregulated upon FLT3 inhibitor exposure in FLT3-mutated AML cells and subsequently enhanced HDAC8 binding and deacetylation of p53 to promote AML cell survival and TKI resistance (106, 107) (Figure 3D).